EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex-based differences in antibody-mediated rejection among highly sensitized kidney transplant recipients

Evelyn Hermida iD, Carolt Arana iD, Jordi Rovira iD, Edoardo Melilli iD, Francesc Moreso, Marta Crespo iD, Carme Facundo, Anna Vila-Santandreu, Maria José Perez-Saez, Alexandre Favà, Cinthia Baldallo, Cristina Canal und 6 weitere

Clinical Kidney Journal · 02.11.2026 · 19 (11)

DOI: 10.1093/ckj/sfag367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 19.10.2026. Verfasst von Evelyn Hermida und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Kidney Transplantation, Institut Clínic de Nefrologia i Urologia (ICNU), Hospital Clínic de Barcelona, Barcelona, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III-Subdirección General de Evaluación, Redes de Investigación Cooperativa Orientadas a Resultados en Salud, NextGenerationEU /Mecanismo para la Recuperación y la Resiliencia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antibody-mediated rejection (AMR) remains a major determinant of graft failure in kidney transplantation, particularly among highly sensitized recipients. Whether biological sex independently influences the incidence and determinants of AMR in this high-risk population remains uncertain. We hypothesized that recipient sex may be associated with early AMR risk beyond conventional immunologic risk factors. We therefore evaluated the association between sex and early AMR, explored sex-specific immunologic determinants, and assessed the impact of AMR on long-term graft survival.

Methods

We performed a multicenter retrospective cohort study of 438 highly sensitized deceased-donor kidney transplant recipients with calculated panel reactive antibody ≥90% transplanted in Catalonia, Spain, between 2015 and 2021. The primary outcome was AMR within the first post-transplant year. Secondary outcomes included 5-year death-censored graft survival and sex-specific associations with AMR. Median follow-up was 42.5 months.

Results

Within the first year, 51 recipients (11.6%) developed AMR. Men exhibited a higher incidence of AMR compared with women (16.2% vs. 8.5%; P = .01). In sex-stratified analyses, antibody strength was the dominant determinant in men, whereas human leukocyte antigen DQ beta 1 (HLA-DQB1) eplet mismatch was more strongly associated with AMR in women, although formal interaction testing was not statistically significant. AMR occurring within the first year was the strongest predictor of 5-year graft failure (hazard ratio 8.3; P < .001), while recipient sex was not independently associated with graft loss.

Conclusions

In highly sensitized recipients, male sex was modestly associated with early rejection. AMR emerged as the main driver of long-term graft loss. The impact of epitope-level HLA mismatch on AMR risk may differ between sexes, particularly at the HLA-DQB1 locus, and warrants further investigation.

Schlagwörter

Stichwörter der Autor:innen

HLA-DQ eplet mismatchantibody-mediated rejectiondonor-specific antibodieshighly sensitized recipientssex differences

Autor:innen und Institutionen

  • Department of Nephrology and Kidney Transplantation, Institut Clínic de Nefrologia i Urologia (ICNU), Hospital Clínic de Barcelona, Barcelona, Spain.
  • Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • RICORS 2040 RD 21/0005/0022, Barcelona, Spain.
  • Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.
  • Nephrology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

ORCID-Profile: Evelyn Hermida, Carolt Arana, Jordi Rovira, Edoardo Melilli, Marta Crespo

Förderung

  • Instituto de Salud Carlos III-Subdirección General de Evaluación
  • Redes de Investigación Cooperativa Orientadas a Resultados en Salud
  • NextGenerationEU /Mecanismo para la Recuperación y la Resiliencia
  • Secretaria d’Universitats i Recerca & CERCA Programme del Departament d’Economia i Coneixement de la Generalitat de Catalunya

Zitieren

APA

Hermida, E., Arana, C., Rovira, J., Melilli, E., Moreso, F., Crespo, M., Facundo, C., Vila-Santandreu, A., Perez-Saez, M. J., Favà, A., Baldallo, C., Canal, C., Paúl-Martinez, J., Comas, J., Tort, J., Palou, E., Diekmann, F., & Ventura-Aguiar, P. (2026). Sex-based differences in antibody-mediated rejection among highly sensitized kidney transplant recipients. Clinical Kidney Journal, 19(11). https://doi.org/10.1093/ckj/sfag367

Vancouver

Hermida E, Arana C, Rovira J, Melilli E, Moreso F, Crespo M, et al. Sex-based differences in antibody-mediated rejection among highly sensitized kidney transplant recipients. Clinical Kidney Journal. 2026;19(11). doi:10.1093/ckj/sfag367

BibTeX
@article{Hermida2026,
  author = {Hermida, Evelyn and Arana, Carolt and Rovira, Jordi and Melilli, Edoardo and Moreso, Francesc and Crespo, Marta and Facundo, Carme and Vila-Santandreu, Anna and Perez-Saez, Maria José and Favà, Alexandre and Baldallo, Cinthia and Canal, Cristina and Paúl-Martinez, Javier and Comas, Jordi and Tort, Jaume and Palou, Eduard and Diekmann, Fritz and Ventura-Aguiar, Pedro},
  title = {Sex-based differences in antibody-mediated rejection among highly sensitized kidney transplant recipients},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1093/ckj/sfag367}
}
Kostenlos starten →